Guolian Kang

4.3k total citations
151 papers, 2.0k citations indexed

About

Guolian Kang is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Guolian Kang has authored 151 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Hematology, 60 papers in Genetics and 34 papers in Molecular Biology. Recurrent topics in Guolian Kang's work include Hemoglobinopathies and Related Disorders (52 papers), Iron Metabolism and Disorders (39 papers) and Hematopoietic Stem Cell Transplantation (27 papers). Guolian Kang is often cited by papers focused on Hemoglobinopathies and Related Disorders (52 papers), Iron Metabolism and Disorders (39 papers) and Hematopoietic Stem Cell Transplantation (27 papers). Guolian Kang collaborates with scholars based in United States, China and Canada. Guolian Kang's co-authors include Wing Leung, Jane S. Hankins, Winfred C. Wang, Ashok Srinivasan, Anusha Sunkara, Brandon M. Triplett, Shannon McKinney‐Freeman, Miguel Ganuza, Mari Dallas and David Finkelstein and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Guolian Kang

139 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guolian Kang United States 27 880 526 473 473 311 151 2.0k
Chad Garner United States 27 667 0.8× 889 1.7× 161 0.3× 1.1k 2.2× 362 1.2× 62 2.7k
Markus Metzler Germany 31 787 0.9× 428 0.8× 125 0.3× 718 1.5× 246 0.8× 130 2.8k
Enrico M. Novelli United States 25 990 1.1× 1.2k 2.2× 270 0.6× 470 1.0× 212 0.7× 95 2.1k
Carlo Carcassi Italy 29 408 0.5× 263 0.5× 1.1k 2.3× 327 0.7× 134 0.4× 115 2.5k
Pierre Lévy France 32 488 0.6× 483 0.9× 172 0.4× 576 1.2× 153 0.5× 115 3.2k
C. Birbara United States 23 1.8k 2.0× 531 1.0× 1.9k 4.1× 354 0.7× 91 0.3× 43 5.5k
Robert W. Lindeman Australia 19 790 0.9× 731 1.4× 112 0.2× 348 0.7× 163 0.5× 78 1.8k
Bobby P. C. Koeleman Netherlands 30 2.8k 3.2× 882 1.7× 666 1.4× 757 1.6× 201 0.6× 72 5.3k
Michael Krämer Germany 31 1.4k 1.6× 534 1.0× 223 0.5× 693 1.5× 125 0.4× 103 2.9k
Karin Potthoff Germany 20 419 0.5× 109 0.2× 397 0.8× 828 1.8× 249 0.8× 60 2.3k

Countries citing papers authored by Guolian Kang

Since Specialization
Citations

This map shows the geographic impact of Guolian Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guolian Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guolian Kang more than expected).

Fields of papers citing papers by Guolian Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guolian Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guolian Kang. The network helps show where Guolian Kang may publish in the future.

Co-authorship network of co-authors of Guolian Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Guolian Kang. A scholar is included among the top collaborators of Guolian Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guolian Kang. Guolian Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazewski, Claire, Sarah Leary, Guolian Kang, et al.. (2025). Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group. Neuro-Oncology. 27(10). 2726–2737. 3 indexed citations
2.
Kang, Guolian, et al.. (2025). Mode Selection for Device to Device Communication in Dynamic Network: A Statistical and Deep Learning Method. Mathematics. 13(3). 343–343. 2 indexed citations
3.
Potter, B.S., Allison A. King, Jeffrey M. Gossett, et al.. (2024). Utility of caregiver signaling questions to detect neurocognitive impairment in children with sickle cell disease. Blood Advances. 9(3). 645–657.
4.
Howell, Kristen E., et al.. (2023). Health literacy correlates with abbreviated full‐scale IQ in adolescent and young adults with sickle cell disease. Pediatric Blood & Cancer. 70(5). e30281–e30281. 1 indexed citations
5.
Okhomina, Victoria, et al.. (2023). Longitudinal effect of disease‐modifying therapy on left ventricular diastolic function in children with sickle cell anemia. American Journal of Hematology. 98(6). 838–847. 2 indexed citations
6.
Persaud, Yogindra, Belinda N. Mandrell, Akshay Sharma, et al.. (2023). Attitudes toward COVID‐19 vaccine among pediatric patients with sickle cell disease and their caregivers. Pediatric Blood & Cancer. 70(5). e30274–e30274. 6 indexed citations
7.
Wang, Winfred C., R. Clark Brown, Zora R. Rogers, et al.. (2023). Intensive hydroxyurea dosing in very young children with sickle cell anemia. Blood Advances. 7(22). 6931–6935. 2 indexed citations
8.
Estepp, Jeremie H., et al.. (2022). Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease. Pharmaceutics. 14(5). 1065–1065. 3 indexed citations
9.
Sharma, Akshay, Alexis Leonard, Kamille A. West, et al.. (2022). Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor‐mobilized patients with sickle cell disease. British Journal of Haematology. 198(4). 740–744. 13 indexed citations
10.
Joshi, Vijaya M., Amber M. Yates, Victoria Okhomina, et al.. (2021). Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia. Blood Advances. 5(1). 89–98. 6 indexed citations
11.
Heitzer, Andrew M., Jeffrey M. Gossett, Lara Ouellette, et al.. (2021). Academic Performance of Children With Sickle Cell Disease in the United States: A Meta-Analysis. Frontiers in Neurology. 12. 786065–786065. 22 indexed citations
12.
Browne, Emily, Anusha Sunkara, Guolian Kang, et al.. (2020). Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial. Journal of Pediatric Oncology Nursing. 37(6). 390–397. 2 indexed citations
13.
Harreld, Julie H., Robert A. Kaufman, Guolian Kang, et al.. (2020). Utility of Pre-Hematopoietic Cell Transplantation Sinus CT Screening in Children and Adolescents. American Journal of Neuroradiology. 41(5). 911–916. 3 indexed citations
14.
Flanagan, Jonathan M., Guolian Kang, Wenjian Bi, et al.. (2019). GSTM1 and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload. Journal of Clinical Medicine. 8(11). 1878–1878. 2 indexed citations
15.
Hodges, Jason, Justin Williams, Sheila Anderson, et al.. (2017). Caregiver Perceptions of Adolescent Self-Management Skills Predicts Higher Disease Knowledge Among Adolescents with SCD. Blood. 130. 3350–3350. 1 indexed citations
16.
Hall, Trent, Megan Walker, Per Holmfeldt, et al.. (2017). Nfix  Promotes Survival of Immature Hematopoietic Cells Via Regulation of C-Mpl. Blood. 130. 2423. 1 indexed citations
17.
Koh, Kyung‐Nam, Anusha Sunkara, Guolian Kang, et al.. (2017). Acute Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes. Biology of Blood and Marrow Transplantation. 24(4). 758–764. 37 indexed citations
18.
Triplett, Brandon M., Guolian Kang, Shane J. Cross, et al.. (2015). Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion. Blood. 126(23). 624–624. 1 indexed citations
19.
Yeung, Edwina, Cuilin Zhang, Jinbo Chen, et al.. (2011). Polymorphisms in the Neuropeptide Y Gene and the Risk Of Obesity: Findings from Two Prospective Cohorts. The Journal of Clinical Endocrinology & Metabolism. 96(12). E2055–E2062. 34 indexed citations
20.
Kang, Guolian, Guimin Gao, Sanjay Shete, et al.. (2011). Capitalizing on Admixture in Genome-Wide Association Studies: A Two-Stage Testing Procedure and Application to Height in African-Americans. SHILAP Revista de lepidopterología. 2. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chad Garner Breakdown of academic impact, for papers by Markus Metzler Breakdown of academic impact, for papers by Enrico M. Novelli Breakdown of academic impact, for papers by Carlo Carcassi Breakdown of academic impact, for papers by Pierre Lévy Breakdown of academic impact, for papers by C. Birbara Breakdown of academic impact, for papers by Robert W. Lindeman Breakdown of academic impact, for papers by Bobby P. C. Koeleman Breakdown of academic impact, for papers by Michael Krämer Breakdown of academic impact, for papers by Karin Potthoff
Rankless by CCL
2026